Target Therapy in Thyroid Cancer: Current Challenge in Clinical Use of Tyrosine Kinase Inhibitors and Management of Side Effects

Thyroid cancer (TC) is the most common endocrine malignancy. TC is classified as differentiated TC (DTC), which includes papillary and follicular subtypes and Hürthle cell variants, medullary TC (MTC), anaplastic TC (ATC), and poorly differentiated TC (PDTC). The standard of care in DTC consists of...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Puliafito, Ivana, Esposito, Francesca, Prestifilippo, Angela, Marchisotta, Stefania, Sciacca, Dorotea, Vitale, Maria Paola, Giuffrida, Dario
Format: Online Artikel Text
Sprache:English
Veröffentlicht: Frontiers Media S.A. 2022
Schlagworte:
Endocrinology
Online Zugang:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304687/
https://www.ncbi.nlm.nih.gov/pubmed/35872981
http://dx.doi.org/10.3389/fendo.2022.860671

Online

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304687/
https://www.ncbi.nlm.nih.gov/pubmed/35872981
http://dx.doi.org/10.3389/fendo.2022.860671

Ähnliche Einträge